Rights and permissions
About this article
Cite this article
RESTORE vision loss in DME - ranibizumab economically viable?. Pharmacoecon. Outcomes News 655, 7 (2012). https://doi.org/10.2165/00151234-201206550-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206550-00023